{"id":"https://openalex.org/W2149698378","doi":"https://doi.org/10.1046/j.1360-0443.2001.9668234.x","title":"Examining the limits of the buprenorphine interdosing interval: daily, every\u2010third\u2010day and every\u2010fifth\u2010day dosing regimens","display_name":"Examining the limits of the buprenorphine interdosing interval: daily, every\u2010third\u2010day and every\u2010fifth\u2010day dosing regimens","alternate_titles":[],"publication_year":2001,"publication_date":"2001-06-01","ids":{"openalex":"https://openalex.org/W2149698378","doi":"https://doi.org/10.1046/j.1360-0443.2001.9668234.x","mag":"2149698378","pmid":"https://pubmed.ncbi.nlm.nih.gov/11399214"},"language":"en","primary_location":{"id":"doi:10.1046/j.1360-0443.2001.9668234.x","doi":"https://doi.org/10.1046/j.1360-0443.2001.9668234.x","is_oa":false,"landing_page_url":"https://doi.org/10.1046/j.1360-0443.2001.9668234.x","pdf_url":null,"source":{"id":"https://openalex.org/S70513841","display_name":"Addiction","issn_l":"0965-2140","issn":["0965-2140","1360-0443"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-a","doyens","erih-plus","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Addiction","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2149698378"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5085905942","display_name":"Nancy M. Petry","orcid":"https://orcid.org/0000-0003-2462-1752","observed_orcids":["https://orcid.org/0000-0003-2462-1752"]},"institutions":[{"id":"https://openalex.org/I111236770","display_name":"University of Vermont","ror":"https://ror.org/0155zta11","country_code":"US","type":"education","lineage":["https://openalex.org/I111236770"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Nancy M. Petry","raw_affiliation_strings":["Departments of Psychiatry and Psychology, University of Vermont, USA. petry@psychiatry.uchc.edu","University of Vermont, Departments of Psychiatry, Psychology"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Departments of Psychiatry and Psychology, University of Vermont, USA. petry@psychiatry.uchc.edu","institution_ids":["https://openalex.org/I111236770"]},{"raw_affiliation_string":"University of Vermont, Departments of Psychiatry, Psychology","institution_ids":["https://openalex.org/I111236770"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5081714379","display_name":"Warren Kurt Bickel","orcid":"https://orcid.org/0000-0002-1048-7372","observed_orcids":["https://orcid.org/0000-0002-1048-7372"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Warren K. Bickel","raw_affiliation_strings":["Medical Biostatistics, Substance Abuse Treatment Center, 1 South Prospect Street, Burlington, VT, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medical Biostatistics, Substance Abuse Treatment Center, 1 South Prospect Street, Burlington, VT, USA","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5108794206","display_name":"Gary J. Badger","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Gary J. Badger","raw_affiliation_strings":["Medical Biostatistics, Substance Abuse Treatment Center, 1 South Prospect Street, Burlington, VT, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medical Biostatistics, Substance Abuse Treatment Center, 1 South Prospect Street, Burlington, VT, USA","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":4600,"currency":"USD","value_usd":4600},"apc_paid":null,"fwci":4.7746,"has_fulltext":false,"cited_by_count":44,"reviewed_by_count":0,"citation_normalized_percentile":{"value":0.94264491,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":86,"max":94},"biblio":{"volume":"96","issue":"6","first_page":"823","last_page":"834"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10576","display_name":"Opioid Use Disorder Treatment","score":0.9980000257492065,"subfield":{"id":"https://openalex.org/subfields/2739","display_name":"Public Health, Environmental and Occupational Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10576","display_name":"Opioid Use Disorder Treatment","score":0.9980000257492065,"subfield":{"id":"https://openalex.org/subfields/2739","display_name":"Public Health, Environmental and Occupational Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11199","display_name":"Pain Management and Opioid Use","score":0.0008999999845400453,"subfield":{"id":"https://openalex.org/subfields/2703","display_name":"Anesthesiology and Pain Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10043","display_name":"Substance Abuse Treatment and Outcomes","score":0.00039999998989515007,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/buprenorphine","display_name":"buprenorphine","score":1.0},{"id":"https://openalex.org/keywords/opioid-use-disorder","display_name":"opioid use disorder","score":0.6679999828338623},{"id":"https://openalex.org/keywords/opioid-withdrawal-symptoms","display_name":"opioid withdrawal symptoms","score":0.7590000033378601},{"id":"https://openalex.org/keywords/dosing-interval","display_name":"dosing interval","score":0.6940000057220459},{"id":"https://openalex.org/keywords/extended-release-buprenorphine","display_name":"extended-release buprenorphine","score":0.7269999980926514},{"id":"https://openalex.org/keywords/duration-of-action","display_name":"duration of action","score":0.6819999814033508},{"id":"https://openalex.org/keywords/patient-preferences","display_name":"patient preferences","score":0.6190000176429749},{"id":"https://openalex.org/keywords/opioid-substitution-therapy","display_name":"opioid substitution therapy","score":0.5609999895095825}],"concepts":[{"id":"https://openalex.org/C2777288759","wikidata":"https://www.wikidata.org/wiki/Q4164182","display_name":"Dosing","level":2,"score":0.9723663926124573},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8076232671737671},{"id":"https://openalex.org/C2778949969","wikidata":"https://www.wikidata.org/wiki/Q407721","display_name":"Buprenorphine","level":4,"score":0.7478715777397156},{"id":"https://openalex.org/C42219234","wikidata":"https://www.wikidata.org/wiki/Q131130","display_name":"Anesthesia","level":1,"score":0.5485915541648865},{"id":"https://openalex.org/C2781413609","wikidata":"https://www.wikidata.org/wiki/Q7308373","display_name":"Regimen","level":2,"score":0.4918048679828644},{"id":"https://openalex.org/C2781063702","wikidata":"https://www.wikidata.org/wiki/Q427523","display_name":"Opioid","level":3,"score":0.4676726758480072},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.21759262681007385},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.209130197763443},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000704","descriptor_name":"Analysis of Variance","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001071","descriptor_name":"Appointments and Schedules","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002047","descriptor_name":"Buprenorphine","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D004311","descriptor_name":"Double-Blind Method","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004334","descriptor_name":"Drug Administration Schedule","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009293","descriptor_name":"Opioid-Related Disorders","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D009294","descriptor_name":"Narcotics","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D010349","descriptor_name":"Patient Compliance","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013375","descriptor_name":"Substance Withdrawal Syndrome","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017060","descriptor_name":"Patient Satisfaction","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1046/j.1360-0443.2001.9668234.x","doi":"https://doi.org/10.1046/j.1360-0443.2001.9668234.x","is_oa":false,"landing_page_url":"https://doi.org/10.1046/j.1360-0443.2001.9668234.x","pdf_url":null,"source":{"id":"https://openalex.org/S70513841","display_name":"Addiction","issn_l":"0965-2140","issn":["0965-2140","1360-0443"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-a","doyens","erih-plus","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Addiction","raw_type":"journal-article"},{"id":"pmid:11399214","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/11399214","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Addiction (Abingdon, England)","raw_type":"Clinical Trial"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.98580002784729,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Clinical Trial","id":"https://openalex.org/study-designs/clinical-trial"}],"awards":[{"id":"https://openalex.org/G2648452733","display_name":"BUPRENORPHINE PHARM RELATED TO ADDICTION TREATMENT","funder_award_id":"R01DA006969","funder_id":"https://openalex.org/F4320337347","funder_display_name":"National Institute on Drug Abuse"},{"id":"https://openalex.org/G8305456715","display_name":"TREATMENT FOR DUALLY DEPENDENT METHADONE PATIENTS","funder_award_id":"R29DA012056","funder_id":"https://openalex.org/F4320337347","funder_display_name":"National Institute on Drug Abuse"},{"id":"https://openalex.org/G8449467925","display_name":"Prize CM for Cocaine Dependent Methadone Patients","funder_award_id":"R01DA013444","funder_id":"https://openalex.org/F4320337347","funder_display_name":"National Institute on Drug Abuse"},{"id":"https://openalex.org/G9000877695","display_name":"Behavioral Pharmacology of Human Drug Use Disorders","funder_award_id":"T32DA007242","funder_id":"https://openalex.org/F4320337347","funder_display_name":"National Institute on Drug Abuse"}],"funders":[{"id":"https://openalex.org/F4320332161","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88"},{"id":"https://openalex.org/F4320337347","display_name":"National Institute on Drug Abuse","ror":"https://ror.org/00fq5cm18"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":19,"referenced_works":["https://openalex.org/W1964118804","https://openalex.org/W1966282663","https://openalex.org/W1979184030","https://openalex.org/W1980315117","https://openalex.org/W1990905986","https://openalex.org/W1995107146","https://openalex.org/W2002091306","https://openalex.org/W2005869962","https://openalex.org/W2041999318","https://openalex.org/W2048334325","https://openalex.org/W2063539450","https://openalex.org/W2068839310","https://openalex.org/W2074176517","https://openalex.org/W2087280110","https://openalex.org/W2097145370","https://openalex.org/W2133801459","https://openalex.org/W2170552179","https://openalex.org/W2260306037","https://openalex.org/W2400263999"],"related_works":["https://openalex.org/W2005869962","https://openalex.org/W2166989066","https://openalex.org/W2074176517","https://openalex.org/W2048334325","https://openalex.org/W1964118804","https://openalex.org/W2061161214","https://openalex.org/W2092356971","https://openalex.org/W2006164129","https://openalex.org/W1995107146","https://openalex.org/W1847209976"],"abstract_inverted_index":{"AIMS:":[0],"Opioid-dependent":[1],"outpatients":[2],"may":[3],"be":[4,18],"more":[5],"likely":[6],"to":[7,156],"present":[8],"for":[9,38,82],"pharmacological":[10],"treatment":[11],"if":[12],"less":[13,237],"than":[14,238],"daily":[15,48,87,100,114,154,245],"dosing":[16,32,41,80,174,185,196,218,222],"can":[17],"arranged.":[19],"These":[20,225],"studies":[21],"compared":[22],"opioid":[23,149],"withdrawal":[24,150,189],"symptoms":[25,151,190],"during":[26,139,193],"24-,":[27],"72-,":[28],"and":[29,34,111,131,145,179,202],"120-hour":[30],"buprenorphine":[31,235],"regimens":[33,81,175],"evaluated":[35],"participants'":[36],"preferences":[37],"these":[39],"different":[40,184],"regimens.":[42,143,186],"PARTICIPANTS:":[43],"Thirty-three":[44],"opioid-dependent":[45],"participants":[46,73,168],"received":[47,169],"sublingual":[49],"maintenance":[50,88,101,115,246],"doses":[51,89],"of":[52,66,85,148,158,167,171,209,232,234],"4":[53],"mg/70":[54,61,96,109,123],"kg":[55,62],"(n":[56,63],"=":[57,64],"14)":[58],"or":[59,94,107,121],"8":[60,95],"19)":[65],"liquid":[67],"buprenorphine.":[68],"METHODS:":[69],"In":[70,161,205],"Study":[71,162,210],"I":[72],"received,":[74],"in":[75,198],"a":[76,164],"random":[77],"order,":[78],"three":[79,173],"five":[83,242],"repetitions":[84],"each:":[86],"every":[90,103,117],"24":[91,108],"hours":[92,105,119],"(4":[93],"kg),":[97],"triple":[98],"the":[99,113,136,140,172,183,194,200,206,229,244],"dose":[102,116,247],"72":[104],"(12":[106],"kg)":[110],"quintuple":[112],"120":[118],"(20":[120],"40":[122],"kg).":[124],"Doses":[125],"were":[126,133,152],"administered":[127,134],"under":[128,176],"double-blind":[129],"procedures,":[130],"placebos":[132],"on":[135],"interposed":[137],"days":[138,240],"latter":[141],"two":[142],"Subjective":[144],"observer":[146],"ratings":[147],"assessed":[153],"prior":[155],"receipt":[157],"each":[159,170],"dose.":[160],"II,":[163,211],"new":[165],"group":[166],"open-dosing":[177,203],"procedures":[178],"then":[180],"chose":[181,216],"between":[182],"FINDINGS:":[187],"Opioid":[188],"increased":[191],"significantly":[192],"every-fifth-day":[195],"regimen":[197],"both":[199],"blind-":[201],"studies.":[204],"choice":[207],"phase":[208],"only":[212],"one":[213],"participant":[214],"(7%)":[215],"quintuple-every-fifth-day":[217],"over":[219],"all":[220],"other":[221],"options.":[223],"CONCLUSIONS:":[224],"results":[226],"suggest":[227],"that":[228],"maximum":[230],"duration":[231],"action":[233],"is":[236,248],"5":[239],"when":[241],"times":[243],"provided.":[249]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2149698378","counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":1},{"year":2023,"cited_by_count":1},{"year":2021,"cited_by_count":1},{"year":2020,"cited_by_count":1},{"year":2018,"cited_by_count":1},{"year":2017,"cited_by_count":1},{"year":2016,"cited_by_count":1},{"year":2015,"cited_by_count":1},{"year":2014,"cited_by_count":1}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2016-06-24T00:00:00"}
